Connect with us

Moderna Affirms Vaccine is Secure for Teens


Moderna Affirms Vaccine is Secure for Teens

Credit: Unsplash

Having received my full vaccination a few weeks ago, I am quite content with the outcome. I no longer harbor as much fear being close to others, and though I still opt to wear a mask in public settings, I noticed a significant number of people out shopping and socializing last weekend, some with masks and others without. It appears that we are gradually returning to a sense of normalcy, but we are not completely in the clear yet. It remains crucial to prioritize the safety of children against COVID-19, which includes ensuring the safety of vaccines for them.

Recent clinical findings released by Moderna suggest that their vaccine, one of the three primary COVID vaccines alongside Pfizer and Johnson & Johnson, is deemed safe for teenagers. While the results have just surfaced and are pending peer review, it may take some time before Moderna vaccines are deemed suitable for adolescents aged 12-17. However, the findings indicate a positive trajectory.

During the trial phase, involving 3,732 adolescents, blood tests revealed that every participant demonstrated an immune response to the vaccine, mirroring immune responses observed in adults. While the trials primarily focused on safety rather than efficacy, it was noted that two weeks post the second vaccine dose, none of the participants displayed evident COVID-19 symptoms, unlike the control group who received a placebo vaccine and subsequently fell ill. No significant adverse effects to the vaccine were noted. The participants did experience some minor side effects like headaches, fatigue, and sore arms, all of which fell within expected range.

Moderna intends to promptly forward these results for peer review and aims to seek authorization from the US Food and Drug Administration next month to administer the vaccine to adolescents.

More in News



To Top